Form 4: Charles Schwab CRO Executes Stock Option Exercise
Statement of Changes in Beneficial Ownership
Chief Risk Officer Nigel J. Murtagh exercised 41,297 stock options and sold the resulting shares under a 10b5-1 plan.
Summary
- Nigel J. Murtagh, Chief Risk Officer of The Charles Schwab Corporation, exercised 41,297 nonqualified stock options at a strike price of $52.05.
- The acquired shares were subsequently sold at a weighted average price of $99.0029 per share.
- The transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 25, 2025.
- Following the transaction, the reporting person retains direct ownership of 57,972.4846 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the transaction was pre-planned and represents routine equity management by an executive.
Positives
- The transaction was pre-planned under a Rule 10b5-1 trading plan, indicating the sale was not based on non-public information.
- The reporting person maintains a significant remaining equity stake of 57,972.4846 shares.
Negatives
- The transaction represents a divestment of 41,297 shares by a key member of the executive leadership team.
Risks
- Executive stock sales can sometimes be perceived by the market as a signal of management's view on current valuation.
Future Outlook
No specific forward-looking guidance regarding company performance was provided in this filing.
Industry Context
StockSavvy.ai notes that executive stock sales executed via 10b5-1 plans are standard corporate practice for liquidity and diversification, and generally do not reflect a change in the executive's outlook on the company's long-term prospects.
Comparison to Industry Standards
- The use of Rule 10b5-1 plans is the industry standard for executives to sell shares while avoiding potential insider trading liability.
- The scale of the sale is consistent with typical executive compensation and equity management practices at large-cap financial institutions.
Stakeholder Impact
- Minimal impact on shareholders as the transaction was conducted through a pre-established 10b5-1 plan.
Next Steps
- No future actions or milestones were disclosed in this filing.
Key Dates
| Date | Description |
|---|---|
| 2025-11-25 | Date the Rule 10b5-1 trading plan was adopted. |
| 2026-04-14 | Date of the option exercise and subsequent share sale. |
| 2026-04-15 | Date of the filing signature. |
Keywords
Charles Schwab, SCHW, Insider Trading, Form 4, Stock Options, Chief Risk Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.